Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Lin Chou

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Patient Preference and Adherence|August 8, 2015
No gynecologist in town: the gynecological care of women in rural TaiwanLi-Jung Lai, Chia-Lin Chou, H Irene Su, et al.
Patient Preference and Adherence|May 24, 2014
Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claimsBih-Ru Wang, Yuh-Lih Chang, Tzeng-Ji Chen, et al.
Oncology|May 15, 2020
High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent ChemoradiotherapyCheng-Yi Lin, Pei-Ling Hsieh, Chia-Lin Chou, et al.
Virchows Archiv : an International Journal of Pathology|November 26, 2024
Low CXCL11 expression is indicative of poor prognosis in rectal cancer patients undergoing preoperative chemoradiotherapy: a retrospective cohort studyChia-Lin Chou, Cheng-Yi Lin, Wan-Shan Li, et al.
American Journal of Surgery|August 30, 2011
Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institutionChia-Lin Chou, Shih-Ching Chang, Tzu-Chen Lin, et al.
Frontiers in Oncology|January 2, 2023
Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysisYu-Hsuan Kuo, Yun-Tzu Lin, Chung-Han Ho, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic BiomarkerKhaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, et al.
Pathology, Research and Practice|April 7, 2020
Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapyMing-Jen Sheu, Chia-Lin Chou, Ching-Chieh Yang, et al.
Cancer Management and Research|November 3, 2021
Optimal Lymph Node Yield for Survival Prediction in Rectal Cancer Patients After Neoadjuvant TherapyYu-Min Lin, Chia-Lin Chou, Yu-Hsuan Kuo, et al.
Diagnostics (Basel, Switzerland)|February 13, 2025
Correction: Ong et al. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. <i>Diagnostics</i> 2023, <i>13</i>, 2296Khaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Patient Preference and Adherence|August 8, 2015
No gynecologist in town: the gynecological care of women in rural TaiwanLi-Jung Lai, Chia-Lin Chou, H Irene Su, et al.
Patient Preference and Adherence|May 24, 2014
Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claimsBih-Ru Wang, Yuh-Lih Chang, Tzeng-Ji Chen, et al.
Oncology|May 15, 2020
High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent ChemoradiotherapyCheng-Yi Lin, Pei-Ling Hsieh, Chia-Lin Chou, et al.
Virchows Archiv : an International Journal of Pathology|November 26, 2024
Low CXCL11 expression is indicative of poor prognosis in rectal cancer patients undergoing preoperative chemoradiotherapy: a retrospective cohort studyChia-Lin Chou, Cheng-Yi Lin, Wan-Shan Li, et al.
American Journal of Surgery|August 30, 2011
Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institutionChia-Lin Chou, Shih-Ching Chang, Tzu-Chen Lin, et al.
Frontiers in Oncology|January 2, 2023
Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysisYu-Hsuan Kuo, Yun-Tzu Lin, Chung-Han Ho, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic BiomarkerKhaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, et al.
Pathology, Research and Practice|April 7, 2020
Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapyMing-Jen Sheu, Chia-Lin Chou, Ching-Chieh Yang, et al.
Cancer Management and Research|November 3, 2021
Optimal Lymph Node Yield for Survival Prediction in Rectal Cancer Patients After Neoadjuvant TherapyYu-Min Lin, Chia-Lin Chou, Yu-Hsuan Kuo, et al.
Diagnostics (Basel, Switzerland)|February 13, 2025
Correction: Ong et al. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. <i>Diagnostics</i> 2023, <i>13</i>, 2296Khaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, et al.
Pageof 6